Value Sense
HSCS
Heart Test Laboratories, Inc. (HSCS)
Last Price$2.95.0%
Market Cap$2,541.3M
LTM Return on Capital Employed (ROCE)
0.5%
5Y avg
13.2%
Medical - Devices industry median
(20.2%)
Stock quality & Intrinsic value
5/10
114.5% undervalued
HSCS
is 11,448.4% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Heart Test Laboratories, Inc. Return on Capital Employed (ROCE)

Annual
Quarterly
LTM
Industry median
Company stand-alone
HSCS
Healthcare
Crunching data... Almost there!
Apr'20Apr'21Apr'22Apr'23Apr'24
Return on Capital Employed (ROCE)
(471.8%)
(360.7%)
1,274.5%
(1,340,106.4%)
(137.0%)
HSCS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for HSCS and see if it's the right time to invest.
Dive in

Heart Test Laboratories, Inc. (HSCS) Return on Capital Employed (ROCE) comparison analysis

General

LTM Return on Capital Employed (ROCE)

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

Heart Test Laboratories, Inc. logo
Heart Test Laboratories, Inc.HSCS
0.5%
261.2%
(99.7%)
(35,511.9%)
Median Peer Set
8.8%
4.2%
59.2%
12.5%
Abbott Laboratories logo
Abbott LaboratoriesABT
21.0%
4.6%
134.5%
31.9%
Insulet Corporation logo
Insulet CorporationPODD
16.8%
22.1%
101.7%
20.2%
Edwards Lifesciences Corporation logo
Edwards Lifesciences CorporationEW
11.9%
(9.4%)
202.2%
76.7%
DexCom, Inc. logo
DexCom, Inc.DXCM
11.4%
11.3%
(1.4%)
14.3%
Stryker Corporation logo
Stryker CorporationSYK
9.2%
10.2%
(5.8%)
13.2%
STERIS plc logo
STERIS plcSTE
8.4%
3.6%
257.9%
7.4%
Boston Scientific Corporation logo
Boston Scientific CorporationBSX
7.4%
17.6%
16.7%
11.1%
Medtronic plc logo
Medtronic plcMDT
6.6%
3.6%
(2.1%)
11.4%
Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc.ZBH
6.3%
3.8%
(9.4%)
11.8%
Koninklijke Philips N.V. logo
Koninklijke Philips N.V.PHG
(2.7%)
(0.8%)
122.5%
(3.9%)

HSCS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Apr'20Apr'21Apr'22Apr'23Apr'24
Revenue
% growth
0.1
0.0%
0.0
(60.1%)
0.0
(43.9%)
0.0
(64.2%)
0.0
261.2%
Cost of Goods Sold (COGS)0.00.00.00.00.0
Gross Profit
% margin
0.0
27.6%
0.0
58.3%
0.0
45.1%
0.0
45.7%
0.0
67.3%
Operating Expenses3.82.64.76.16.3
Research & Development Expenses (R&D)2.01.73.02.52.9
Selling, General & Administrative Expenses (SG&A)1.80.91.73.73.4
Operating Income
% margin
(3.8)
(5,949.0%)
(2.6)
(10,030.2%)
(4.7)
(32,765.6%)
(6.1)
(118,698.3%)
(6.3)
(33,902.0%)
Interest Income0.00.10.40.20.0
Interest Expense0.00.10.40.20.4
Pre-tax Income(3.8)(2.5)(4.8)(6.4)(6.6)
Income Tax
% effective tax rate
0.0
(0.6%)
0.1
(5.3%)
(0.3)
5.2%
484.5
(7,624.8%)
0.0
0.0%
Net Income
% margin
(3.8)
(5,973.4%)
(2.6)
(10,081.1%)
(4.6)
(31,851.8%)
(490.9)
(9,531,151.3%)
(6.6)
(35,511.9%)
EPS(115.69)(77.89)(137.94)(6,173.88)(18.74)
Diluted EPS(115.69)(77.89)(137.94)(6,173.88)(18.74)
EBITDA
% margin
(3.7)
(5,834.2%)
(2.3)
(8,928.7%)
(4.4)
(30,822.2%)
(6.1)
(118,139.8%)
(6.2)
(33,096.7%)

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Heart Test Laboratories, Inc.'s Return on Capital Employed (ROCE)?

As of today, Microsoft Corp's last 12-month Return on Capital Employed (ROCE) is 0.5%, based on the financial report for Oct 31, 2024 (Q4’2024). The average annual Return on Capital Employed (ROCE) for Heart Test Laboratories, Inc. have been 13.2% over the past three years, and 9.9% over the past five years.

2) Is Heart Test Laboratories, Inc.'s Return on Capital Employed (ROCE) Good?

As of today, Heart Test Laboratories, Inc.'s Return on Capital Employed (ROCE) is 0.5%, which is higher than industry median of (20.2%). It indicates that Heart Test Laboratories, Inc.'s Return on Capital Employed (ROCE) is Good.

3) How does Heart Test Laboratories, Inc.'s Return on Capital Employed (ROCE) compare to its peers?

As of today, Heart Test Laboratories, Inc.'s Return on Capital Employed (ROCE) is 0.5%, which is lower than peer median of 8.8%. The list of peers includes ABT, PODD, EW, DXCM, SYK, STE, BSX, MDT, ZBH, PHG.